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ABSTRACT
Degenerative process is an accumulation of free radicals that can lead to a variety of changes in the cell. This aim of 
the study to see the effects of different dietary lipid intervention on lipid profi le and lipid peroxidation in female aged 
cynomolgus monkey. Twelve female Cynomolgus monkey (Macaca fascicularis) were randomly divided into 4 dietary groups 
of three animals. Animals were held in individual cages and placed in the position where they can interact individually. 
They were given a normal fat diet with 2% cholesterol and 3% of fat from soybean oil and 9% of lipid as beef tallow 
(BFT), catfi sh oil (CFO), fermented catfi sh oil (FCFO) and soybean oil (SBO). Evaluation of their body weights, serum lipid 
profi le and cholesterol content consumption were done monthly except an index of lipid peroxidation were performed 
before and after 12 weeks intervention. Animal group that consumed the feed more than 82% has body weight gain, such 
as CFO and BFT. On the other side, animal group that consumed less than 70% has body weight loss, such as FCFO. There 
was no effect (p > 0.05) of the experimental diets on decreasing triglyceride levels and increasing HDL cholesterol level. 
Cynomolgous given BFT, CFO, and FCFO diet for 3 months showed signifi cantly increased (p < 0.05) in total cholesterol 
and LDL cholesterol level, but the monkeys fed with SBO showed lower levels. Statistically, All of diet interventions do not 
signifi cantly affect on lipid peroxidation in LDL (p < 0.05). In general it can be concluded that catfi sh oil signifi cantly 
cause elevated levels of total cholesterol and LDL cholesterol in blood serum, but not in the HDL plasma.
Keywords: Catfi sh oil; serum cholesterol; lipid profi le; lipid peroxidationa
ABSTRAK
Proses degeneratif adalah pengumpulan radikal bebas yang boleh membawa kepada pelbagai perubahan dalam sel. Tujuan 
kajian adalah melihat pengaruh pemberian dari berbagai sumber lemak terhadap pada profi l lipid dan pengoksidaan 
lipid pada monyet ekor panjang betina tua. Dua belas monyet ekor panjang betina (Macaca fascicularis) secara rawak 
dibahagikan kepada 4 kelompok dan setiap kelompok terdiri daripada 3 haiwan. Macaca diletakkan dalam sangkar 
individu dan diposisikan dapat saling berinteraksi dan berkomunikasi. Mereka diberi diet dengan kandungan kolesterol 
2% dan kandungan lemak 12% iaitu 3% lemak berasal daripada minyak kacang soya dan 9% berasal daripada lemak 
yang berbeza iaitu lemak sapi (BFT), minyak ikan lele (CFO), minyak ikan lele yang difermentasi (FCFO), dan minyak 
kacang soya (SBO). Penilaian berat badan mereka, profi l lipid serum dan asupan diet kolesterol dilakukan setiap bulan, 
sedangkan penilaian peroksidasi lipid dilakukan sebelum dan setelah pemberian 12 minggu. Rata-rata konsumsi Macaca 
yang mengkonsumsi diet BFT dan CFO adalah 82%, sedangkan Macaca yang mengkonsumsi FCFO dan SBO hanya 70%. 
Tidak ada kesan (p > 0.05) daripada diet eksperimen mengurangkan kadar trigliserida dan meningkatkan kadar kolesterol 
HDL. Macaca yang diberikan diet BFT, CFO, dan FCFO menunjukkan peningkatan ketara (p < 0.05) dalam total kolesterol 
dan LDL kolesterol, tetapi monyet diberi makan SBO menunjukkan kadar total kolesterol dan LDL kolesterol yang rendah. 
Semua pemberian diet secara statistik (p < 0.05) tidak memberi pengaruh terhadap pengoksidaan lipid dalam LDL. Oleh 
kerana itu, secara umumnya dapat disimpulkan bahawa pemberian minyak ikan lele hanya menyebabkan peningkatan 
kadar kolesterol total dan LDL kolesterol serum dalam serum darah, tetapi tidak dalam plasma HDL.
Kata kunci: Minyak ikan lele; kolesterol serum; profi l lipid; pengoksidaan lipid
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INTRODUCTION
BACKGROUND
Cardiovascular diseases (CVDs) are responsible for 
signifi cant mortality and morbidity throughout the world 
including Indonesia (WHO, 2003). Their causation is due 
to atherosclerosis and/or thrombosis. These process can be 
initiated from an unbalanced eating habits such as excessive 
fat consumption regardless of the type and amount that 
will increase the level of low-density lipoprotein (LDL) 
in the blood. Elevated blood cholesterol levels especially 
LDL is the primary target of cholesterol-lowering therapy 
to reduce cardiovascular diseases risk (Mc. Cance et al. 
2010). Diet is one of an important thing in the prevention 
and treatment of CVD. To date, many studies reported that 
different dietary lipids can modulate plasma cholesterol 
levels, depending on their fatty acid composition (Cintra 
et al. 2006). 
 In a recent meta-analysis of fourteen cohort and fi ve 
case-control studies, fi sh consumption was associated 
with a 20% reduction in the relative risk of fatal and a 
10% reduction in non fatal atherosclerosis (Hamer & 
Steptoe 2006). Morise et al. 2004 has reported that high 
levels of saturated fatty acid (SFAs) are associated with 
the formation of atherosclerotic plaques. However, intake 
of mono unsaturated fatty acids (MUFAs) especially oleic 
acid and polyunsaturated fatty acids (PUFAs) especially 
α linolenic acid, are associated with decreased risk of 
cardiovascular death. Many studies have also demonstrated 
that MUFAs and PUFAs show similar effects on lowering 
blood cholesterol when SFA is substituted in the diet (Cintra 
et al. 2006). Although PUFA are effective at lowering blood 
LDL cholesterol, at intake in excess of 8-10% dietary energy 
they also lower HDL cholesterol concentration, necessary 
for atherogenic protection. PUFA are also susceptible to 
metabolic oxidation and high intakes can enhance lipid 
peroxidation and free radical production with potentially 
adverse effects in terms of atherogenesis and carcinogenesis 
(Thomas & Bishop 2007).
 Catfi sh oil was the ‘by product’ in the production 
of catfi sh fl our can be used as the source of a healthy fat, 
which is still under utilized. Our preliminary study had 
shown that the catfi sh oil shows a high content of saturated 
fatty acid (SFA), monounsaturated fatty acid (MUFA) and 
polyunsaturated fatty acid (PUFA). The dominant content 
of unsaturated fatty acids such as oleic acid (C18:1) has 
about 22.82% and 17.8% of linoleic acid (C18:2). The 
excess of linoleic acid content could be desaturated and 
elongated to be other types of essential fatty acid such as 
arachidonic and gamma linolenic and if fermented with 
lactic acid bacteria the content of conjugated linoleic acid 
(CLA) increased (Hidayati 2005; Xu et al. 2004; dan Ogawa 
et al. 2001). This study aims to look at the effect of cat fi sh 
oil fi sh (CFO), fermented catfi sh oil (FCFO), beef tallow 
(BFT), and soybean oil (SBO) on the lipid profi le and lipid 
peroxidation in cynomolgous monkey. 
Cynomolgous monkey (Macaca fascicularis) is one of 
Indonesian native primates which belongs to the kingdom 
of Animalia, Phylum: chordates, Subphyllum: Vertebrates, 
Class of Mammals, Order of: Primates and Suborder : 
Anthropoida. Cynomolgous monkey has the advantage to 
be used in biomedical research due to in their the present 
of antibodies to certain types of viruses (Adyanto, 2010).
This monkey also has a very close phylogenetic 
relationship to humans that they have physiological and 
anatomical similarities (Smith et al. 2010). They also had a 
small bodies that complete information about the reactions 
to hormonal diets; e.g. if the ovarectomized cynomolgus 
are given atherogenic food feeding for at least 3 months, 
there will be an increase of total cholesterol concentration 
in the plasma and the decrease of high-density cholesterol 
(Williams & Suparto 2004). Various studies had suggested 
that animal studies using monkeys as experiment model 
has the best similarities with humans. 
MATERIALS & METHODS
EXPERIMENTAL DESIGN
Experimental studies with a completely randomized design 
(CRD), which analyzes the effect of catfi sh oil (CFO) and 
fermented catfi sh oil (FCFO) on lipid profi le in female aged 
cynomolgus monkey (Macaca fascicularis). The animal 
welfare committee of ethics PT. Bimana Indomedical Bogor 
with ACUC number of P.03.12_IR approved all animal 
care and experimental protocols. Twelve female aged 
cynomolgus (Macaca fascicularis) which age are over 10 
years old, and body weight in the range of 2.780 to 3.3 kg. 
All animals have been ovarectomized and were purchased 
from PT IndoAnilab Bogor, Indonesia. Cynomolgous were 
held in individual cages placed in the position where it 
can interact individually. The adaptation process needed 2 
months period and the animals had been given 100 grams 
each per day of standard feeding of Purina Monkey Chow. 
During this time, cynomolgous consumed feed and water 
ad libitum. Cynomolgous were then randomly assigned to 
1 of 4 treatment groups for 12 weeks (n=3/group/period). 
Each group was given food intervention containing 0.2% 
cholesterol and isocaloric. 
The amount of feeding given was 120 gram/day, 60 
grams in the morning and 60 grams in the afternoon The 
leftover feeding were weight everyday and water were 
consumed ad libitum. Bodyweight and waist circumference 
were measured every month. Blood sample also was taken 
every month. Prior to the blood sampling, subjects were 
anasthesized using 10 mg per 10 kg body weight. Blood 
was taken through the femoral vein, put it into the tube and 
maintained at a temperature of 4C for the analysis of lipid 
profi le and lipid peroxidation.
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DIET FORMULATION
The raw material of Catfish oil obtained from PT 
Carmelitha Lestari Bogor. Beef tallow oil obtained 
from PT. Garuda Mas Lestari Bekasi and soybean oil is 
obtained from PT. Indofood Jakarta. The intervention diet 
(Table 1) were prepared and pelleted by PT. Carmelitha 
Lestari Bogor. Total fat content of the diets was 12% by 
weight, 9% of which was supplied by respective treatment 
fats. All diets were supplemented with 0.2% cholesterol 
by weight. The addition of cholesterol to the diets was to 
induce hyperlipidemia, thereby enhancing the detectable 
effects of treatments. The composition of feeding was 
based on food composition table per 100 grams can be 
seen on Table 2. All diets were designed to have the 
same contain of nutrient such as protein, fat and CHO, 
but fatty acid composition are different between each 
other depend on type of oil given. All feeding has both 
saturated fatty acid (SFA), unsaturated fatty acids either 
mono-unsaturated fatty acids (MUFA) or poly-unsaturated 
fatty acids (PUFA). The BFT and SBO treatments served 
as appropriate controls, because they are different, such 
as the BFT is source of SFA, but the SBO is source of 
PUFA. Fatty acids content in several types of feeding was 
illustrated in Table 3.
PLASMA LIPID AND LIPID PEROXIDATION
Materials for lipid profi le analysis is Liquicolor Bavaria 
Cholesterol Test Kit, while the materials needed for lipid 
peroxidation analysis are bovine serum albumin (BSA), sodium 
carbonate (Na2CO3), sodium bicarbonate (NaHCO3), copper 
sulfate (CUSO4.5H2O), potassium tartrate, sodium hydroxide 
TABLE 1. Food intervention composition
Raw food material  BFT  CFO FCFO SBO
Flour (gram) 38 38 38 38
Maizena (gram) 10 10 10 10
Skim milk powder (gram) 10 10 10 10
Fish powder (gram) 7 7 7 7
Soy paste (gram) 5.8 5.8 5.8 5.8
Rice bran (gram) 2 3 2 3
Sugar (gram) 1 10 10 10
Soybean oil (gram) 3 12 3 3
Beef tallow (gram) 9 - - -
Catfi sh oil (gram)   - 9
Fermented catfi sh oil (gram)   9 -
Margarin (gram) 1 - 2 -
Agar-agar (gram) 1 1 0.5 1
CMC (gram) 1 1 0.5 1
Mineral mix (gram) 1 1 1 1
Mineral (gram) 1 1 1 1
Cholesterol (gram) 0.2 0.2 0.2 0.2
Total (gram) 100 100 100 100
Note:  BFT = beef tallow, CFO = catfi sh oil, FCFO = fermented catfi sh oil, SBO = 
soybean oil
TABLE 2. Nutrition content in food *)
Component  BFT  SBO CFO FCFO
Energy 398 397 396 400
Fat  13.5 13.5 13.5 13.5
Protein 13.4 13.4 13.4 13.4
Carbohydrate 55.8 55.8 55.9 55.8
% protein to energy 13.5 13.5 13.5 13.4
% fat to energy 30. 30.1 30 30.8 
% CHO to energy 56 56.4  56.5  53.8
Note:  *) based on food composition table
 BFT = beef tallow, CFO = catfi sh oil, FCFO = fermented catfi sh oil, SBO = 
soybean oil
TABLE 3. Fatty acid composition of BFT, CFO, FCFO, and 
SBO in food (% fatty acid)
Fatty acid  BFT  CFO FCFO SBO
C8:0 - - - -
C10:0 - - - -
C12:0 0.1 - - -
C14:0 0.5 0.2 0.3 -
C16:0 2.9 3 2.9 1.3
C18:0 3.4 0.7 1 0.4
∑SFA 6.8 3.2 4.2 1.7
C14:1 - - - -
C16:1 0.2 1.1 0.3 -
C18:n9c 2.7 3.0 4.2 2.7
∑MUFA 2.9 4.1 4.5 2.7
C18:2n6c 1.9 4 2.6 6.6
C20:0 - - - -
C18:3n3 0.2 0.3 0.3 0.8
C22:0 0.1 0.1 0.05 0.1
C22:1n9 - - 0.1 -
C20:4n6 - - - -
C24:0 - - - -
C20:5n3 - 0.1 0.1 -
C22:6n3 - 0.4 0.1 -
CLA 0.1 - 0.05 -
∑PUFA 2.3 4.8 3.3 7.5
∑ MUFA+PUFA 5.2 8.9 7.8 10.2
∑SFA+MUFA+PUFA 12 12. 12 11.9
P/S 0.3 1.5 0.8 4.4
W6:W3 - 15 : 1 13:1 9:1
Note:  BFT = beef tallow, CFO = catfi sh oil, FCFO = fermented catfi sh oil, SBO = 
soybean oil
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(NaOH), acid ethylenediamine - tetrasetat (EDTA), sodium 
chloride (NaCl), Folin-phenol reagent, potassium bromide 
(KBr), 1,1,3,3-tetrametoksipropana (TMP), trichloroacetic acid 
(TCA), tiobarbiturat acid (TBA), acetic acid, glasiat, ethanol 
and the dialysis bag.
The tools used for the analysis of lipid profi le and 
lipid peroxidation is a low-speed centrifuge with rotor 
Beckman Bucket Swing 3750 rpm, ultrasentrifus Beckman 
XL-90 to SW-40 rotor, polialomer tube (14 × 95 mm), tube 
slicer knife, glass tools, UV-VIS spectrophotometer DMS 
100 (Varian), vortex, milipore 0.45 um fi lter, water bath 
and pipette tip.
STATISTICAL ANALYSIS
The data obtained are presented in the form of the average 
and standard deviation. All data were analyzed with 
analysis of variance test at 5% level test. Duncan difference 
test is only done when a real treatment effect (p < 0.05). 
RESULTS
CONSUMPTION AND PHYSICAL CHANGES
Various responses to the feeding consumption was shown 
during the intervention. Table 4 illustrates the average 
and percentage of various feeding consumption during 
the intervention. Data showed that the acceptance to CFO 
was pretty good. Consumption of CFO reached more than 
80% of the served food was not much different from the 
consumption of the feeding containing BFT. Fat functioned 
as something that improved the palability of meal on CFO. 
Different chemical structures can also affect the taste of 
fat (Piliang 2006). Treatment of various types of feeding 
caused the physical changes to subjects that include the 
body weight, waist circumference, and body mass index 
(BMI). Figure 1 presented graph the percentage of physical 
changes in Subjects.
TABLE 4. Feed consumption and precentage in all groups
Intervention Food weight Average Precentage
 (gram) consumption consumption
  (gram)  (%)
BFT 120 107.00 ± 5.90 89.17
CFO 120 98.78 ± 16.48 82.32
FCFO 120 75.08 ± 11.53 62.57
SBO 120 85.89 ± 18.63 71.57
Note: BFT = beef tallow, CFO = catfi sh oil, FCFO = fermented catfi sh oil, SBO = 
soybean oil
FIGURE 1. Precentage of weight, weist circumstances and BMI changes
Graph in Figure 1 shows that the intervention group 
treated with BFT and CFO have increased body weight 
respectively by 10% and 8%, while the group fed by SBO 
and FCFO have decreased body weight respectively by 
17% and 2%.
All treated group had increased waist circumference 
by more than 5%. IMT changes happened to all groups but 
not for subjects which given SBO feeding. The group given 
the BFT and CFO got increasing of 12% and 2% respectively 
while the group given the FCFO decrease of 17%.
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LIPID PROFILE
Lipid profi le is one of the tools to determine the presence 
of or absence of lipid disorders in the body which is known 
as dyslipidemia. Dyslipidemia is a major risk factor for 
atherosclerosis. Lipid profi le includes triglycerides, total 
cholesterol, LDL and HDL. Table 5 illustrates the Subjects 
lipid profi le during intervention.
TRIGLYCERIDE PROFILE
Table 5 shows that the average level of triglyceride 
before the intervention in the group that was given CFO, 
the average levels increase continuously. Before the 
intervention the triglyceride average level was 52.67 ± 
16.92 mg/dl. Triglyceride levels increased continuously 
during intervention to reach 97.00 ± 67.51 mg/dl in the 
3rd month. Intervention using BFT and SBO feeding in 
cynomolgous showed the same modulation of the level of 
triglyceride. The average level of triglyceride before the 
intervention in the group given the BFT and SBO feeding 
in row is 56.00 ± 1.00 mg/dl and 67.00 ± 42.58 mg/dl. 
The average of triglyceride level then increased to 152.50 
± 5.50 mg/dl (BFT) and 84.00 ± 41.68 mg/dl (SBO) in the 
3rd month.
Intervention using FCFO feeding showed different 
modulation by other group. In this group average of 
triglyceride levels increased from 42.7 ± 9.29 mg/dl before 
intervention to 72.67 ± 68.73 mg/dl in the 1st month. 
However in the 2nd month the average of triglyceride 
levels decreased to 57.00 ± 19.28 mg/dl. This decline 
didn’t continue because in the 3rd month the average of 
triglyceride levels increased sharply to reach back to 108.67 
± 23.80 mg/dl.
TOTAL CHOLESTEROL LEVELS
Profi le of total cholesterol in the group that were given BFT 
and CFO feeding showed an almost similar modulation. It 
can be seen in Table 5 that the average cholesterol levels 
in both groups are increasing. The average total cholesterol 
in the group which was given BFT before intervention was 
173.50 ± 12.50 mg/dl and group given CFO was 157.67 ± 
19.55 mg/dl. After 3 month intervention, the average of 
cholesterol level has increased sharply to reach 276.00 
± 111.00 mg/dl in the group fed by BFT, and the average 
total cholesterol levels of group given CFO increased from 
157.67 ± 19.55 to reach 372.67 ± 10.97 mg/dl. The total 
cholesterol levels that continued to decline was shown by 
the group fed SBO. In this group, the declined of the average 
of total cholesterol levels continued from 139.33 ± 15.04 
mg/dl before the intervention to 117.67 ± 23.44 mg/dl in 
the 3rd month of intervention.
LDL PROFILE
LDL profi le of the group that were fed with BFT and CFO 
showed an increase of LDL levels continuously from the 
beginning until the end of intervention. Table 5 showed 
that the average of LDL of pre-intervention level of the BFT 
TABLE 5. Average lipid profi le (mg/dl)
Lipid profi le Month CFO FCFO BFT SBO
Triglyceride 0 52.67±16.921 42.67±9.291 56.00±1.0023 67.00±42.581
 1 61.67±20.501 72.67±68.731 50.00±3.003 61.33±23.181
 2 84.33±66.861 57.00±19.281 74.00±18.002 69.00±24.631
 3 97.00±67.511 108.67±23.801 152.50± 5.501 84.00±41.681
Average  83.42±53.99a 80.29±26.71a 97.44±8.06a 72.71 ±29.88a
Total Chol. 0 157.67±19.553 141.00±40.781 173.50±12.502 139.33±15.041
 1 255.33±62.682 263.33±87.951 266.00±12.5012 119.00±50.691
 2 260.33±72.882 228.67±33.851 271.00±92.001 121.67±37.871
 3 372.67 ±10.971 211.67±79.001 276.00±111.001 117.67±23.441
Average  301.21±39.8a 230.9±21.02ab 271.63±84.13a 119.5±34.56b
LDL Chol. 0 37.00±10.003 36.33±30.111 53.50±11.502 38.33±27.32
 1 86.33±56.703 152.00±123.261 78.50±13.5012 10.67±10.02
 2 164.33±85.102 170.00±73.181 112.50±6.512 40.6±1.27
 3 306.00+±18.081 133.33±98.741 194.00±16.01 39.20±13.00
  197.96±9.95a 151.75±49.98a 134.56±49.32a 32.59±10.56ab
HDL Chol 0 120.0±22.272 102.33±23.81 109.00±24.0012 87.33±33.251
 1 171.00±22.001 97.00±51.21 177.5±19.501 112.67±55.721
 2 79.00±26.893 49.33±47.431 144.00±82.001 106.67±50.331
 3 47.00±16.464 56.3±27.541 51.50±6.502 61.67±21.501
  90.00±19.55a 63.8±35.41a 117.69±33.19a 91.29±33.60a
Note:  Numbers followed by different numbers of test results indicate signifi cantly different between months (p < 0.05), while the letter shows the test results were signifi cantly 
different between treatments
 BFT = beef tallow, CFO = catfi sh oil, FCFO = fermented catfi sh oil, SBO = soybean oil
JSKM12(2) 3.indd   21 08/12/2014   14:31:00
22
and CFO group are 53.50 ± 11.50 mg/dl and 37.00 ± 10.00 
mg/dl. The average LDL levels in both groups increased 
sharply to reach 194.00 ± 116.00 mg/dl (BFT) and 306.00 
± 18.08 mg/dl (CFO) in the 3rd month.
An increase in the average of LDL levels after 3 months 
of intervention also occurred in the group that were fed 
with FCFO and SBO. However both groups showed different 
modulations compared to other groups. In the group of 
Subjects fed with FCFO the average of LDL levels before 
the intervention were 36.33 ± 30.11 mg/dl. The average 
LDL levels then increased sharply up to 152.00 ± 123.26 
mg/dl in the 1st month but decreased to 102.00 ± 19.28 mg/
dl in the 2nd month. At the 3rd month the average levels of 
LDL increased again to 133.33 ± 98.74 mg/dl. Despite the 
decline, levels of LDL is still higher than the LDL levels 
before the intervention.
The group that were fed with SBO showed different 
LDL modulation compared to other groups. Before the 
intervention, the average levels of cholesterol was 38.33 ± 
27.32 mg/dl. The average levels of LDL decrease until 10.67 
± 10.02 mg/dl in the 1st month but the average increased 
again in the 2nd month to 40.6 ± 1.27 mg/dl and increased 
again to 39.20 ± 13.00 in the 3rd month.
HDL LEVELS
In Table 5 it can be seen that the average HDL levels in all 
groups decreased after intervention by giving them all types 
all of feeding. The group that were given BFT, CFO, and 
SBO showed a similar modulation. Before the intervention, 
the average level of HDL in the groups that were given BFT, 
CFO and SBO feeding in a row were 109.00 ± 24.00 mg/dl, 
120.00 ± 22.27 mg/dl and 87.33 ± 33.25 mg/dl.
In the 1st month the average levels of HDL in the 
group given BFT feeding peaked at 177.50 ± 19.50 mg/dl 
and decreased in the 3rd month to 51.50 ± 6.50 mg/dl. The 
same modulation occurred in the group fed with CFO and 
SBO. In the group fed by CFO feeding, the average of HDL 
levels peaked at the 1st month to 171.00 ± 22.00 mg/dl then 
declined again to 47.00 ± 16.46 mg/dl in the 3rd month.
In the group fed SBO feeding, the average HDL levels 
peaked at the 1st month to 112.67 ± 55.72 mg/dl and then 
declined again until 61.7 ± 21.50 mg/dl in the 3rd month. 
The groups fed with FCFO feeding showed different 
modulation with other groups. The average levels of HDL 
before intervention was 102.33 ± 23.80 mg/dl. Average 
of HDL decreased continuously until 49.33 ± 47.43 mg/
dl and a slight increased to 56.33 ± 27.54 mg/dl in the 
3rd month. 
LIPID PEROXIDATION
Lipid peroxidation is a mechanism of cellular injury 
which is used as an indicator of oxidative stress in cells 
and tissues. LDL oxidation in principle a chain reaction 
of lipid peroxidation induced by free radicals. One of the 
products of lipid oxidation is malondialdehida (MDA). 
In Figure 2, it can be seen that the levels of MDA in LDL 
change after the intervention. All treatment groups were 
seen to have elevated levels of MDA in LDL. Increased 
levels of MDA in LDL highest experienced by the group 
fed CFO is from 0.21 nmol/mg before intervention into 
0.815 nmol/mg after the intervention. In contrast, the 
lowest increase experienced by the group fed SBO of 0.11 
nmol/mg before the intervention to be 0.155 nmol/mg 
after the intervention. However, no statistically signifi cant 
treatment effect with increased levels of MDA in LDL.
FIGURE 2. MDA levels pre and post intervention
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DISCUSSION
PHYSICAL CHANGES
Oil catfi sh and catfi sh oil fermentation can be considered as 
a source of energy because it gives energy equals to other 
oil that is ± 9 kcal for every 1 gram of oil. Pekenpaugh 
(2010) stated that fat accounts for higher energy than 
protein and carbohydrate because the have more carbon 
bond in its structure. The evidence showed that the group 
that consumed more feeding got an increasing and waist 
circumference compared to the groups which got less 
feeding (< 70%).
Bowman et al. (2006) stated that the ± 70% of energy 
intake in the elderly, particularly on animal study, may slow 
the aging process, prolong the life expectancy and inhibit 
chronic diseases associated with age. Though mechanism 
in the body is unclear but it is suspected that the reduction 
of 30% energy can reduce the metabolic rate in oxidative 
stress, improve insulin sensitivity and change the neuro 
endocrine and symphatetic nervous system function.
Weight loss will not happen continuously and will stop 
at some point. Results show that within 3 months the weight 
change will already fi x. It means that within the period of 3 
months the cynomolgous have been able to adapt the diet 
so that the body weight can be maintained.
TRIGLYCERIDE LEVELS
Triglycerides are the form of fat stored in the body that are 
found in the adipose tissue. Some triglycerides circulate 
in the blood and they are used as energy in the muscles 
to work. All treated groups experienced increasing 
triglyceride levels (p > 0.05). The increased of triglyceride 
levels in the blood of all treated groups ranged from 4.44 – 
39.17 mg/dl. Oberman (2000) suggested that the increased 
levels of triglycerides by 90 mg/dl may increase the risk 
of cardiovascular disease by 32%.
The increase in triglyceride serum is often associated 
with VLDL synthesis and its distribution. Triglyceride 
synthesis in the liver is regulated by the availability of 
both free fatty acid derived from the amount of glycogen 
in the liver and the status of insulin and glucagon hormones 
in particular. No single factor is affecting the increase 
of triglycerides. Other factors are the relationship with 
the disorders of bile acid metabolism and the production 
of abundant triglycerides, obesity, carbohydrate Intake 
and excess of saturated fatty acid, less activity and 
hyperglycemic (Stipanuk 2000).
TOTAL CHOLESTEROL LEVELS AND LDL CHOLESTEROL
Total and LDL cholesterol profi les showed that all groups 
showed classic modulation levels of hypercholesterolemia 
towards atherogenic feeding with the exception of 
the SBO group. Results showed that the total and LDL 
cholesterol levels in the cynomolgous which were given 
BFT, CFO and FCFO during intervention did not show 
signifi cant differences, but the groups given SBO feeding 
got a signifi cant different result with the other groups 
(p < 0.05).
Mitruka and Rawnsky (1977) stated that normal levels 
of total cholesterol serum in cynomolgous ranged between 
100-150 mg/dl, while normal levels of LDL cholesterol 
was 68 ± 9 mg/dl (Lubis 1993). Results showed that 
only the group given with SBO showed that the levels of 
cholesterol and LDL were considered normal which is 
117.67 ± 23.44 mg/dl for cholesterol and 39.20 ± 13 mg/
dl for LDL levels.
 Based on the ratio of P/S, the CFO, FCFO, BFT, and 
SBO are 1.5, 0.8, 0.3 and 4.4, while Kang et al. (2005) 
stated that P/S Ratio between 1-1.5 is the best to reduce 
the risk of atherogenesis. This opinion is supported by 
Muller et al. (2003) which stated that to lower the total 
SFA without balancing the P/S Ratio will not decrease the 
LDL Cholesterol level. The P/S ratio is the maximal point 
which can affect the regulation of total cholesterol serum. 
This research showed that the increasing total Cholesterol 
serum was not infl uenced by the P/S ratio., e.g. catfi sh oil 
with P/S ratio 1.5 is not able to suppress the increasing 
total cholesterol and LDL. This presumably because there 
are other affecting factors such as the high amount of SFA. 
IOM (2002) stated that the limit of SFA is 7%, and the only 
one that has SFA < 7% is only SBO.
The increasing levels of serum cholesterol and LDL 
is one strong indication of the risk of coronary heart 
disease (Garg & Simha 2007). LDL function is to carry 
cholesterol from the liver to the tissues. Normal levels of 
LDL Cholesterol are controlled by the hepatic LDL receptor 
that binds LDL and limits Lipoprotein synthesis the liver. 
The reduced formation of LDL receptors will cause the 
circulating amount of cholesterol in the blood above normal 
(Kasim et al. 2006).
There are several types of LDL. The most atherogenic is 
the LDL particles with low density, but it was not measured 
in the study. The menopause female subjects generally 
have smaller LDL particles compared to premenopause 
women (Krummel & Krisetherton 1996). Moreover the 
absence of estrogen hormone also affects the increasing 
rate of LDL serum and total cholesterol. This will result 
in hyperglycemic condition that can not be controlled 
therefore the lipid and lipoprotein metabolism is not normal 
(Peckenpaugh 2007).
Another factor that is suspected in infl uencing the 
value is the internal factor of Subjects such as abdominal 
obesity. Results of this study indicated that the increased 
waist circumference in Subjects is apparently has positive 
effect with the increased levels of cholesterol, LDL 
Cholesterol and triglycerides (p < 0.05). It is in accordance 
with the opinion of Jalal et al. (2006) who stated that the 
waist circumference is one of the best indicator metabolic 
syndrome including dyslipidemia.
Binkoski et al. (2005) reported that PUFA from 
vegetable sources can lower total cholesterol and LDL 
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levels. CFO, FCFO, BFT are oil derived from animal. 
Binkoski et al. (2005) also stated that although the amount 
and types of fat is similar but if the source of saturated and 
fats unsaturated is different then the results will be different 
too. Kromhout et al. (2011) added that fat restriction did 
not give important effect. What is were important is the low 
content of saturated fatty acids. Therefore it proved that 
only SBO feedings are able to maintain the levels of total 
cholesterol and LDL levels to remain at normal level. 
HDL LEVELS
On lipid metabolism in the body, HDL has the opposite 
mechanism with LDL, which is free of cholesterol transport 
to the liver tissue to be removed from the body or converted 
into bile acids through a mechanism known as reverse 
cholesterol transport. HDL also plays a role in endothelial 
repair and reduce thrombosis. HDL can be broken down 
into several particle density (HDL 2 and HDL 3) or by 
size (large, medium, and small). The most effective HDL 
transports cholesterol from the tissues back to the liver, 
and HDL 2 as a better indicator than total atherogenic HDL 
(Murray et al. 2003).
Statistically signifi cant test results showed that all 
groups decreased markedly different to the levels of HDL 
are fed with different types of treatment (p < 0.05). One 
of the causes of decreased levels of HDL are high levels of 
CHO in the diet exceeds 60% of energy. Brehm et al. (2003), 
states that a low CHO diet such as 15% energy, 28% protein 
and 60% fat (20% of the SFA) for 6 months will increase 
HDL levels by 13%.
LIPID PEROXIDATION
Lipid peroxidation is a process that is closely associated 
with free radicals. Lipid peroxidation is generally a 
unifi cation of molecular oxygen into PUFAs in biological 
membranes. PUFA by free radicals occurs in the H atom 
that is unstable, especially if the attached C atom close to 
the double bond, so that the newly formed free radicals 
are very sensitive to oxygen (Sunil & Dinesh 2009). 
Lipid oxidation results will form one of the wide range of 
products including malondialdehida.
Malondialdehida (MDA) is one of the end products 
of lipid peroxidation compounds formed after the radical 
attack of membrane lipids containing polyunsaturated fatty 
acids (PUFA). Cynomolgous monkey is the type of animal 
that has a very close phylogenetic to humans that have 
similarity of aspects of physiology and anatomy. Statistical 
test results showed that the value of MDA in LDL was not 
affected by treatment (p > 0.05). But descriptively seen 
that MDA levels in the Cynomolgous group fed BFT, SBO, 
CFO, and FCFO increased although the increase was within 
normal limits, but the highest increased were found in a 
group given CFO diet.
 MDA levels in LDL were higher in the group with 
Cynomolgous feed CFO who can give bad effects on 
metabolic processes in the body. McCance et al. (2010) 
and Crawford (1993) states that oxidized LDL is toxic to 
endothelial cells, causes smooth muscle proliferation, and 
activates further immune and infl ammation responses. The 
oxidized LDL binds to scavenger receptors of macrophages 
and causes the formation of foam cells. This will stimulate 
the gene expression of a number of cytokines and growth 
factors and lead to proliferation of smooth muscle cells 
at the intima. As a result of blood vessel walls will swell 
due to the accumulation of plaque in the media (Crawford 
1993; Mc Cance et al. 2010).
 However, in the present study, the lipid peroxidation 
value was higher in cynomolgous fed CFO diet rather than 
cynomolgous feed FCFO. This fi nding probably refl ects 
the decreased susceptibility of FCFO because of its high 
monounsaturated fatty acid and conjugated linoleic acid 
(CLA) content compared with CFO. MUFA are regarded as 
the most benefi cial type of fatty acid as they do not have 
a hypercholesterolaemic effect (Thomas & Bishop 2007). 
Egert et al. 2011 reported that a low-fat diet and a high-fat 
diet, both rich in MUFA, had similar effects on serum lipids 
and lipoprotein, LDL sizes and indices of lipid peroxidation 
in metabolically healthy, young and non obesity men and 
women. 
 CONCLUSION
During the intervention the groups which were given 
intervention with CFO and BFT increased the body weight, 
whereas the intervention group given SBO and FCFO had lost 
weight. Intervention with BFT, CFO, FCFO, were increased 
total cholesterol and LDL levels signifi cantly (p < 0.05, but 
intervention with SBO was decreased them. Intervention 
with CFO and FCFO also has the potential increasing of 
triglyceride levels although not statistically signifi cant 
(p > 0.05). Interventions with BFT and CFO signifi cantly 
lowering levels of HDL (p < 0.05), and not signifi cantly 
reduced lipid peroxidation (MDA) in the LDL (p > 0.05). 
In general it can be concluded that catfi sh oil signifi cantly 
cause atherogenic only in blood cholesterol total, but not 
in the HDL plasma. 
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